Literature DB >> 23577464

The use of animals for research on animal diseases: its impact on the harm-benefit analysis.

Michael D Rickard1.   

Abstract

The use of animals in scientific experiments is sometimes controversial. Usually, the debate focuses on the advantages or disadvantages of using animals in biomedical research or for testing products for safety or efficacy in humans. This has been the case in the previous World Congresses on Alternatives and Animal Use in the Life Sciences. Such studies can be subjected to a harm-benefit analysis that attempts to assess the expected benefits of the research to be done in relation to the harm done to the experimental animals. This paper suggests that studies carried out in the target species offer a higher level of fidelity and discrimination (confidence in the proper expression of the disease and greater ability to detect the impacts of any treatments under investigation) than do experiments carried out in animal models of a different species. A number of examples are given to show the benefits that have accrued to the welfare of domesticated animals through research on the diseases from which they suffer. These examples suggest that there will be an ongoing need to use animals in research to develop methods for the control or eradication of newly emergent diseases.

Entities:  

Mesh:

Year:  2004        PMID: 23577464     DOI: 10.1177/026119290403201s37

Source DB:  PubMed          Journal:  Altern Lab Anim        ISSN: 0261-1929            Impact factor:   1.303


  4 in total

Review 1.  Current concepts of Harm-Benefit Analysis of Animal Experiments - Report from the AALAS-FELASA Working Group on Harm-Benefit Analysis - Part 1.

Authors:  Aurora Brønstad; Christian E Newcomer; Thierry Decelle; Jeffrey I Everitt; Javier Guillen; Kathy Laber
Journal:  Lab Anim       Date:  2016-06       Impact factor: 2.471

2.  Evaluation of animal models of neurobehavioral disorders.

Authors:  F Josef van der Staay; Saskia S Arndt; Rebecca E Nordquist
Journal:  Behav Brain Funct       Date:  2009-02-25       Impact factor: 3.759

Review 3.  Pediatric Autoimmune Disorders Associated with Streptococcal Infections and Tourette's Syndrome in Preclinical Studies.

Authors:  Chiara Spinello; Giovanni Laviola; Simone Macrì
Journal:  Front Neurosci       Date:  2016-06-30       Impact factor: 4.677

Review 4.  Recommendations for Addressing Harm-Benefit Analysis and Implementation in Ethical Evaluation - Report from the AALAS-FELASA Working Group on Harm-Benefit Analysis - Part 2.

Authors:  Kathy Laber; Christian E Newcomer; Thierry Decelle; Jeffrey I Everitt; Javier Guillen; Aurora Brønstad
Journal:  Lab Anim       Date:  2016-06       Impact factor: 2.471

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.